These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33704629)

  • 1. Preferential tumor localization in relation to
    Tatekawa H; Uetani H; Hagiwara A; Yao J; Oughourlian TC; Ueda I; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Bahri S; Pope WB; Salamon N; Ellingson BM
    J Neurooncol; 2021 May; 152(3):573-582. PubMed ID: 33704629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
    Tatekawa H; Yao J; Oughourlian TC; Hagiwara A; Wang C; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Salamon N; Ellingson BM
    Clin Nucl Med; 2020 Dec; 45(12):e505-e511. PubMed ID: 33031233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas.
    Tatekawa H; Hagiwara A; Uetani H; Yao J; Oughourlian TC; Bahri S; Wang C; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
    J Neurooncol; 2020 Sep; 149(2):337-346. PubMed ID: 32929644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH mutation is paradoxically associated with higher
    Verger A; Metellus P; Sala Q; Colin C; Bialecki E; Taieb D; Chinot O; Figarella-Branger D; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1306-1311. PubMed ID: 28293705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high
    Isal S; Gauchotte G; Rech F; Blonski M; Planel S; Chawki MB; Karcher G; Marie PY; Taillandier L; Verger A
    Br J Radiol; 2018 Apr; 91(1084):20170803. PubMed ID: 29271237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden.
    Tatekawa H; Uetani H; Hagiwara A; Bahri S; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
    Ann Nucl Med; 2021 Sep; 35(9):1022-1029. PubMed ID: 34121166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and grading accuracy of
    Xiao J; Jin Y; Nie J; Chen F; Ma X
    BMC Cancer; 2019 Aug; 19(1):767. PubMed ID: 31382920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of change in maximum
    Oughourlian TC; Yao J; Schlossman J; Raymond C; Ji M; Tatekawa H; Salamon N; Pope WB; Czernin J; Nghiemphu PL; Lai A; Cloughesy TF; Ellingson BM
    J Neurooncol; 2020 Mar; 147(1):135-145. PubMed ID: 31981013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.
    Cobes N; Tran S; Mathon B; Nichelli L; Bielle F; Touat M; Kas A; Rozenblum L
    Eur J Neurol; 2024 Jan; 31(1):e16093. PubMed ID: 37823694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
    Karavaeva E; Harris RJ; Leu K; Shabihkhani M; Yong WH; Pope WB; Lai A; Nghiemphu PL; Liau LM; Chen W; Czernin J; Cloughesy TF; Ellingson BM
    Mol Imaging Biol; 2015 Jun; 17(3):434-42. PubMed ID: 25465392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of dynamic parameters in the analysis of
    Ginet M; Zaragori T; Marie PY; Roch V; Gauchotte G; Rech F; Blonski M; Lamiral Z; Taillandier L; Imbert L; Verger A
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1381-1390. PubMed ID: 31529264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxelwise and Patientwise Correlation of
    Tatekawa H; Hagiwara A; Yao J; Oughourlian TC; Ueda I; Uetani H; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
    J Nucl Med; 2021 Mar; 62(3):319-325. PubMed ID: 32646876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.
    Riva M; Lopci E; Castellano A; Olivari L; Gallucci M; Pessina F; Fernandes B; Simonelli M; Navarria P; Grimaldi M; Rudà R; Castello A; Rossi M; Alfiero T; Soffietti R; Chiti A; Bello L
    World Neurosurg; 2019 Jun; 126():e270-e280. PubMed ID: 30797926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[
    Kosztyla R; Raman S; Moiseenko V; Reinsberg SA; Toyota B; Nichol A
    Br J Radiol; 2019 Jul; 92(1099):20180901. PubMed ID: 31017449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
    Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
    Schwarzenberg J; Czernin J; Cloughesy TF; Ellingson BM; Pope WB; Grogan T; Elashoff D; Geist C; Silverman DH; Phelps ME; Chen W
    Clin Cancer Res; 2014 Jul; 20(13):3550-9. PubMed ID: 24687922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.